BB Biotech’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $141M | Buy |
3,522,964
+130,000
| +4% | +$5.22M | 3.56% | 10 |
|
|
2018
Q4 | $156M | Buy |
3,392,964
+110,000
| +3% | +$5.06M | 5% | 5 |
|
|
2018
Q3 | $146M | Buy |
3,282,964
+100,000
| +3% | +$4.44M | 3.85% | 11 |
|
|
2018
Q2 | $125M | Buy |
3,182,964
+770,000
| +32% | +$30.2M | 3.6% | 12 |
|
|
2018
Q1 | $175M | Buy |
2,412,964
+50,000
| +2% | +$3.62M | 4.82% | 9 |
|
|
2017
Q4 | $156M | Buy |
2,362,964
+265,000
| +13% | +$17.4M | 4.38% | 11 |
|
|
2017
Q3 | $105M | Buy |
2,097,964
+584,422
| +39% | +$29.3M | 2.91% | 13 |
|
|
2017
Q2 | $70M | Buy |
1,513,542
+105,000
| +7% | +$4.86M | 2.14% | 15 |
|
|
2017
Q1 | $49.7M | Buy |
1,408,542
+100,000
| +8% | +$3.53M | 1.63% | 16 |
|
|
2016
Q4 | $16.4M | Hold |
1,308,542
| – | – | 0.61% | 24 |
|
|
2016
Q3 | $18.1M | Buy |
1,308,542
+300,000
| +30% | +$4.15M | 0.64% | 23 |
|
|
2016
Q2 | $9.96M | Hold |
1,008,542
| – | – | 0.39% | 27 |
|
|
2016
Q1 | $17.1M | Buy |
1,008,542
+100,000
| +11% | +$1.69M | 0.68% | 22 |
|
|
2015
Q4 | $20.2M | Hold |
908,542
| – | – | 0.57% | 26 |
|
|
2015
Q3 | $21.4M | Buy |
+908,542
| New | +$21.4M | 0.68% | 25 |
|